Compare VITL & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VITL | EIKN |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 557.9M | 631.0M |
| IPO Year | 2020 | 2026 |
| Metric | VITL | EIKN |
|---|---|---|
| Price | $8.92 | $7.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $13.22 | ★ $24.60 |
| AVG Volume (30 Days) | ★ 1.5M | 518.4K |
| Earning Date | 11-03-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $759,444,000.00 | N/A |
| Revenue This Year | $1.33 | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $7.95 | $7.55 |
| 52 Week High | $45.16 | $16.50 |
| Indicator | VITL | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 35.89 |
| Support Level | $7.95 | N/A |
| Resistance Level | $13.83 | $10.20 |
| Average True Range (ATR) | 0.60 | 0.64 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 7.94 | 12.80 |
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.